Top Markets
Coin of the day
Arch Biopartners Inc. Arch Biopartners Inc.

Arch Biopartners Inc.

ARCH
Pozycja w akcjach #25415
Arch Biopartners Inc. is a biotechnology firm dedicated to devising... Arch Biopartners Inc. is a biotechnology firm dedicated to devising groundbreaking solutions for both medical and commercial applications. A significant focus for the company is the advancement of Metablok, a key therapeutic agent designed to address or avert dipeptidase-1 driven inflammation in critical organs such as the lungs, liver, and kidneys. This inflammatory response can lead to profound organ dysfunction or complete failure, particularly in conditions like sepsis and COVID-19. Moreover, Arch Biopartners is developing AB569, an experimental medication intended to combat antibiotic-resistant bacterial infections, primarily through topical application on wounds. Their innovative product pipeline also features Borg, a specialized peptide-solid surface interface developed to hinder biofilm formation and lessen material corrosion. Lastly, MetaMx involves synthetic compounds engineered to target the cells that initiate brain tumors and invasive glioma cells. The company's operations are based out of Toronto, Canada.
Cena akcji
$0.73393689
Ostatnia synchronizacja: 2026-08-20
Kapitalizacja rynkowa
$49.86M
Zmiana (1 dzień)
-8.26%
Zmiana (1 rok)
-38.15%
Kraj
CA
Handel Arch Biopartners Inc. (ARCH)

Kategoria

Historia ceny akcji dla Arch Biopartners Inc. (ARCH)
Najwyższa cena zamknięcia: $0.80 dnia 2026-08-01

Najniższa cena zamknięcia: $0.24 dnia 2010-05-01
Historia cen akcji firmy Arch Biopartners Inc. od 2010 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -23.16%
2025 -30.82%
2024 20.19%
2023 -48.03%
2022 -33.91%
2021 176.41%
2020 54.21%
2019 -26.71%
2018 185.93%
2017 8.76%
2016 42.45%
2015 -21.16%
2014 48.45%
2013 -6.69%
2012 -40.44%
2011 -46.45%
2010 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$539.14 35.65%
US
$1.04K 56.21%
NL
$118.70 -18.24%
AU
$758.49 8.17%
CH
$130.43 397.46%
US